Venture Capital for Biomedical Research

The strategic role of the private foundations Purnell Choppin observes in this issue (p. 16-17) that “the health of the biomedical research enterprise [in the United States] is inseparable from the health of the NIH.” Since two thirds of federal support for biomedical research in this country goes into or through the NIH, and since that amounts to one third of total national support for basic research in biomedicine, one can only agree with the statement of the president of the How

| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

The strategic role of the private foundations Purnell Choppin observes in this issue (p. 16-17) that “the health of the biomedical research enterprise [in the United States] is inseparable from the health of the NIH.” Since two thirds of federal support for biomedical research in this country goes into or through the NIH, and since that amounts to one third of total national support for basic research in biomedicine, one can only agree with the statement of the president of the Howard Hughes Medical Institute.

Nonetheless, the Hughes organization, which will disburse about $230 million in 1988, is certainly making a mark on the course and character of U.S. biomedical research. With assets of $5 billion and an annual budget comparable to that of a midsized institute at the NIH, HHMI has focused professional and public attention on non-governmental funding sources.

Besides government and industry support for biomedical research, and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Eugene Garfield

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
Discover a serum-free way to produce dendritic cells and macrophages for cell therapy applications.

Optimizing In Vitro Production of Monocyte-Derived Dendritic Cells and Macrophages

Thermo Fisher Logo
Collage-style urban graphic of wastewater surveillance and treatment

Putting Pathogens to the Test with Wastewater Surveillance

An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with Lipid Nanoparticles

Thermo Fisher Logo